Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease

Casin, Kevin M. and Calvert, John W. (2021) Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease. Antioxidants, 10 (3). p. 383. ISSN 2076-3921

[thumbnail of antioxidants-10-00383-v2.pdf] Text
antioxidants-10-00383-v2.pdf - Published Version

Download (1MB)

Abstract

Cardiovascular disease is the leading cause of death in the U.S. While various studies have shown the beneficial impact of exogenous hydrogen sulfide (H2S)-releasing drugs, few have demonstrated the influence of endogenous H2S production. Modulating the predominant enzymatic sources of H2S—cystathionine-β-synthase, cystathionine-γ-lyase, and 3-mercaptopyruvate sulfurtransferase—is an emerging and promising research area. This review frames the discussion of harnessing endogenous H2S within the context of a non-ischemic form of cardiomyopathy, termed diabetic cardiomyopathy, and heart failure. Also, we examine the current literature around therapeutic interventions, such as intermittent fasting and exercise, that stimulate H2S production.

Item Type: Article
Subjects: East India Archive > Agricultural and Food Science
Depositing User: Unnamed user with email support@eastindiaarchive.com
Date Deposited: 11 Jul 2023 04:57
Last Modified: 26 Jun 2024 11:14
URI: http://ebooks.keeplibrary.com/id/eprint/1600

Actions (login required)

View Item
View Item